Presentation is loading. Please wait.

Presentation is loading. Please wait.

A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective.

Published byΕυτύχιος Βάμβας Modified over 5 years ago

Similar presentations

Presentation on theme: "A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective."— Presentation transcript:

1 A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective Study (ACOSOG Z4032)  Michael S. Kent, MD, Sumithra J. Mandrekar, PhD, Rodney Landreneau, MD, Francis Nichols, MD, Nathan R. Foster, MS, Thomas A. DiPetrillo, MD, Bryan Meyers, MD, Dwight E. Heron, MD, MBA, David R. Jones, MD, Angelina D. Tan, BS, Sandra Starnes, MD, Joe B. Putnam, MD, Hiran C. Fernando, MD  The Annals of Thoracic Surgery  Volume 102, Issue 1, Pages (July 2016) DOI: /j.athoracsur Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 The patient Consolidated Standards of Reporting Trials (CONSORT) diagram. (CT = computed tomography; IRB = Institutional Review Board; NSCLC = non-small cell lung cancer; SR = sublobar resection; SRB = sublobar resection plus brachytherapy.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Nomogram for predicting 5-year overall survival (OS). (Dlco = diffusing capacity of lung for carbon monoxide.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Calibration plot for the 5-year overall survival (OS) nomogram.
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective."

Similar presentations

Elizabeth A. David, MD, David T

Elizabeth A. David, MD, David T
Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients  Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,

Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients  Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,
Lymphovascular Invasion as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis  Nathan M. Mollberg, DO,

Lymphovascular Invasion as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis  Nathan M. Mollberg, DO,
Masatsugu Hamaji, MD, Syed Osman Ali, MD, Bryan M. Burt, MD 

Masatsugu Hamaji, MD, Syed Osman Ali, MD, Bryan M. Burt, MD 
Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.
Thomas J. Birdas, MD, Richard P. M

Thomas J. Birdas, MD, Richard P. M
Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non–Small Cell Lung Cancer: A 13-Year Analysis  Amgad El-Sherif, MD, William E. Gooding, MS,

Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non–Small Cell Lung Cancer: A 13-Year Analysis  Amgad El-Sherif, MD, William E. Gooding, MS,
Bryan L. Walker, BS, Christina Williamson, MD, Shawn M

Bryan L. Walker, BS, Christina Williamson, MD, Shawn M
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer

Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer
Does the method of radiologic surveillance affect survival after resection of stage I non– small cell lung cancer?  Traves D. Crabtree, MD, Varun Puri,

Does the method of radiologic surveillance affect survival after resection of stage I non– small cell lung cancer?  Traves D. Crabtree, MD, Varun Puri,
Morbidity and Mortality of Major Pulmonary Resections in Patients With Early-Stage Lung Cancer: Initial Results of the Randomized, Prospective ACOSOG.

Morbidity and Mortality of Major Pulmonary Resections in Patients With Early-Stage Lung Cancer: Initial Results of the Randomized, Prospective ACOSOG.
Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M

Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M
Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J

Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J
Matthew D. Taylor, MD, Alykhan S. Nagji, MD, Castigliano M

Matthew D. Taylor, MD, Alykhan S. Nagji, MD, Castigliano M
Oncologic Outcomes After Surgical Resection of Subcentimeter Non-Small Cell Lung Cancer  Matthew J. Schuchert, MD, Arman Kilic, BS, Arjun Pennathur, MD,

Oncologic Outcomes After Surgical Resection of Subcentimeter Non-Small Cell Lung Cancer  Matthew J. Schuchert, MD, Arman Kilic, BS, Arjun Pennathur, MD,
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Salvage Resections for Recurrent or Persistent Cancer of the Proximal Esophagus After Chemoradiotherapy  Colin Schieman, MD, Dennis A. Wigle, MD, PhD,

Salvage Resections for Recurrent or Persistent Cancer of the Proximal Esophagus After Chemoradiotherapy  Colin Schieman, MD, Dennis A. Wigle, MD, PhD,
Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes  Julie E. Bauman, MD, Michael.

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes  Julie E. Bauman, MD, Michael.
Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Similar presentations

Ads by Google